Search Within

Charles Rudin

  1. "International Journal of Radiation Oncology, Biology, Physics"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  2. Department of Medicine (13)
  3. GSK Faculty (13)
  4. Solid Tumor Oncology Division (13)
  5. Thoracic Oncology (13)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (10)

More Groups

People
  1. Andreas Rimner (8)
  2. Abraham Wu (7)
  3. Daniel Gomez (7)
  4. Daphna Gelblum (6)
  5. Narek Shaverdian (6)
  6. Zhigang Zhang (6)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (2)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (13)
Publishers
  1. Elsevier Inc. (13)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Journal Article

    Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Biomarkers associated with pulmonary exacerbations in a prospective, placebo-controlled, randomized trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Huang, X.; Lobaugh, S.; Geyer, A.; Gelblum, D.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J.; Zauderer, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Standard vs. higher-dose consolidative thoracic radiation in extensive-stage small cell lung cancer
    Meeting Abstract

    Billing, D.; Rimner, A.; Shepherd, A. F.; Gelblum, D.; Shaverdian, N.; Simone, C. B. 2nd; Lai, V.; Rudin, C. M.; Gomez, D. R.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Circulating tumor DNA as a biomarker in oligometastatic non-small cell lung cancer
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y.; Razavi, P.; Reis, J. S.; Flynn, J.; Zhang, Z.; Tu, H. Y.; Bertucci, C.; Lim, L. P.; Li, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab
    Meeting Abstract

    Shaverdian, N.; Shepherd, A. F.; Offin, M.; Lobaugh, S.; Zhang, Z.; Simone, C. B. 2nd; Gelblum, D.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • PARP trapping by talazoparib is a potent mechanism of radiosensitization in small cell lung cancer cell lines and patient-derived xenografts
    Meeting Abstract

    Laird, J. H. Jr; Lok, B. H.; Ma, J.; Bell, A.; De Stanchina, E.; Poirier, J.; Rudin, C. M.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • [(18)F]PARPi PET as a marker of intratumoral talazoparib level in small cell lung cancer
    Meeting Abstract

    Laird, J. H.; Lok, B. H.; Carney, B.; Kossatz, S.; Ma, J.; Bell, A.; Shah, N.; Sadique, A.; De Stanchina, E.; Reiner, T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX)
    Meeting Abstract

    Lok, B. H.; Feng, Y.; Gardner, E. E.; Yu, G. K.; Ru, Y. K.; Riaz, N.; deStanchina, E.; Powell, S. N.; Shen, Y. J.; Poirier, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save